AngioDynamics Reports Fiscal 2017 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
AngioDynamics (ANGO) Tops Q3 EPS by 4c; Adjusted FY17 Revs Lower, EPS Higher
March 30, 2017 6:02 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.19, $0.04 better than the analyst estimate of $0.15. Revenue for the quarter came in at $85.6 million versus the consensus estimate of $88.27 million.
GUIDANCE:
AngioDynamics sees FY2017 EPS of $0.68-$0.70, versus the consensus of $0.67. AngioDynamics sees... More
